Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in N Engl J Med

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KHAN U, Hadid T
    Plasmacytomas and Plasma-Cell Leukemia.
    N Engl J Med. 2017;376:e19.
    PubMed     Text format    


  2. HOCHHAUS A, Larson RA, Guilhot F, Radich JP, et al
    Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.
    N Engl J Med. 2017;376:917-927.
    PubMed     Text format     Abstract available


  3. LONGO DL
    Imatinib Changed Everything.
    N Engl J Med. 2017;376:982-983.
    PubMed     Text format    


  4. KANTARJIAN H, Stein A, Gokbuget N, Fielding AK, et al
    Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.
    N Engl J Med. 2017;376:836-847.
    PubMed     Text format     Abstract available


    February 2017
  5. MONTALBAN-BRAVO G, Takahashi K, Garcia-Manero G
    Decitabine in TP53-Mutated AML.
    N Engl J Med. 2017;376:796-7.
    PubMed     Text format    


  6. WELCH JS, Petti AA, Ley TJ
    Decitabine in TP53-Mutated AML.
    N Engl J Med. 2017;376:797-8.
    PubMed     Text format    


    November 2016
  7. WELCH JS, Petti AA, Miller CA, Fronick CC, et al
    TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
    N Engl J Med. 2016;375:2023-2036.
    PubMed     Text format     Abstract available


  8. MORI J, Tsuda K, Tanimoto T
    Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia.
    N Engl J Med. 2016;375:2100.
    PubMed     Text format    



  9. Inotuzumab Ozogamicin for Acute Lymphoblastic Leukemia.
    N Engl J Med. 2016;375:2100-2101.
    PubMed     Text format    


  10. ESTEY E
    Acute Myeloid Leukemia - Many Diseases, Many Treatments.
    N Engl J Med. 2016;375:2094-2095.
    PubMed     Text format    


    September 2016
  11. MAURY S, Chevret S, Thomas X, Heim D, et al
    Rituximab in B-Lineage Adult Acute Lymphoblastic Leukemia.
    N Engl J Med. 2016;375:1044-53.
    PubMed     Text format     Abstract available


  12. MILANO F, Gooley T, Wood B, Woolfrey A, et al
    Cord-Blood Transplantation in Patients with Minimal Residual Disease.
    N Engl J Med. 2016;375:944-53.
    PubMed     Text format     Abstract available


  13. LEMONNIER F, Inoue S, Mak TW
    Genomic Classification in Acute Myeloid Leukemia.
    N Engl J Med. 2016;375:900-1.
    PubMed     Text format    



  14. Genomic Classification in Acute Myeloid Leukemia.
    N Engl J Med. 2016;375:900-1.
    PubMed     Text format    


    August 2016
  15. OTHUS M, Estey E, Gale RP
    Assessment of Minimal Residual Disease in Standard-Risk AML.
    N Engl J Med. 2016;375:e9.
    PubMed     Text format    


  16. MORIN-ZORMAN S, Renneville A, Ades L
    Assessment of Minimal Residual Disease in Standard-Risk AML.
    N Engl J Med. 2016;375:e9.
    PubMed     Text format    


  17. BACCARANI M
    Assessment of Minimal Residual Disease in Standard-Risk AML.
    N Engl J Med. 2016;375:e9.
    PubMed     Text format    


  18. HILLS RK, Ivey A, Grimwade D
    Assessment of Minimal Residual Disease in Standard-Risk AML.
    N Engl J Med. 2016;375:e9.
    PubMed     Text format    


    July 2016
  19. DAVIDS MS, Kim HT, Bachireddy P, Costello C, et al
    Ipilimumab for Patients with Relapse after Allogeneic Transplantation.
    N Engl J Med. 2016;375:143-53.
    PubMed     Text format     Abstract available


  20. TIBERGHIEN P, Follea G, Muller JY
    Platelet Transfusions in Acute Leukemia.
    N Engl J Med. 2016;375:96-7.
    PubMed     Text format    


    June 2016
  21. GOTLIB J, Kluin-Nelemans HC, George TI, Akin C, et al
    Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.
    N Engl J Med. 2016;374:2530-41.
    PubMed     Text format     Abstract available


  22. LORENZO ME, Carter JB, Barnes JA, Nazarian RM, et al
    CASE RECORDS of the MASSACHUSETTS GENERAL HOSPITAL. Case 19-2016. A 65-Year-Old Man with End-Stage Renal Disease and a Pruritic Rash.
    N Engl J Med. 2016;374:2478-88.
    PubMed     Text format    


  23. KANTARJIAN HM, DeAngelo DJ, Stelljes M, Martinelli G, et al
    Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia.
    N Engl J Med. 2016.
    PubMed     Text format     Abstract available


  24. VINY AD, Levine RL
    Roads Diverge--A Robert Frost View of Leukemia Development.
    N Engl J Med. 2016;374:2282-4.
    PubMed     Text format    


  25. PAPAEMMANUIL E, Gerstung M, Bullinger L, Gaidzik VI, et al
    Genomic Classification and Prognosis in Acute Myeloid Leukemia.
    N Engl J Med. 2016;374:2209-21.
    PubMed     Text format     Abstract available


  26. WALTER HS, Salles GA, Dyer MJ
    New Agents to Treat Chronic Lymphocytic Leukemia.
    N Engl J Med. 2016;374:2185-6.
    PubMed     Text format    


  27. ZAMAN F, Savendahl L
    New Agents to Treat Chronic Lymphocytic Leukemia.
    N Engl J Med. 2016;374:2185.
    PubMed     Text format    


  28. ROBERTS AW, Davids MS, Seymour JF
    New Agents to Treat Chronic Lymphocytic Leukemia.
    N Engl J Med. 2016;374:2186-7.
    PubMed     Text format    


    May 2016
  29. SHAPIRO MF
    Considering the Common Good--The View from Seven Miles Up.
    N Engl J Med. 2016;374:2006-7.
    PubMed     Text format    


    April 2016
  30. RUCHLEMER R, Ami RB, Lachish T
    Ibrutinib for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2016;374:1592-5.
    PubMed     Text format     Abstract available


  31. RIGOLIN GM, Cavazzini F, Cuneo A
    Ibrutinib for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2016;374:1592-5.
    PubMed     Text format     Abstract available


  32. SHARMAN JP, Mato AR, Keating MJ
    Ibrutinib for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2016;374:1592-5.
    PubMed     Text format     Abstract available



  33. Ibrutinib for Chronic Lymphocytic Leukemia.
    N Engl J Med. 2016;374:1592-5.
    PubMed     Text format     Abstract available


    March 2016
  34. LO-COCO F, Di Donato L, Schlenk RF
    Targeted Therapy Alone for Acute Promyelocytic Leukemia.
    N Engl J Med. 2016;374:1197-8.
    PubMed     Text format    



  35. Chimeric Antigen Receptor-Modified T Cells in Chronic Lymphoid Leukemia; Chimeric Antigen Receptor-Modified T Cells for Acute Lymphoid Leukemia; Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia.
    N Engl J Med. 2016;374:998.
    PubMed     Text format     Abstract available


  36. ARMSTRONG GT, Chen Y, Yasui Y, Leisenring W, et al
    Reduction in Late Mortality among 5-Year Survivors of Childhood Cancer.
    N Engl J Med. 2016;374:833-42.
    PubMed     Text format     Abstract available


    February 2016
  37. IVEY A, Hills RK, Simpson MA, Jovanovic JV, et al
    Assessment of Minimal Residual Disease in Standard-Risk AML.
    N Engl J Med. 2016;374:422-33.
    PubMed     Text format     Abstract available


  38. BURKE MJ
    Minimal Residual Disease in NPM1-Mutated AML.
    N Engl J Med. 2016;374:481-2.
    PubMed     Text format    


    January 2016
  39. WILSON WH
    Progress in Chronic Lymphocytic Leukemia with Targeted Therapy.
    N Engl J Med. 2016;374:386-8.
    PubMed     Text format    


    December 2015
  40. BYRD JC, Harrington B, O'Brien S, Jones JA, et al
    Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  41. ROBERTS AW, Davids MS, Pagel JM, Kahl BS, et al
    Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


  42. BURGER JA, Tedeschi A, Barr PM, Robak T, et al
    Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    November 2015
  43. EGAN JM
    Targeting Stem Cells in Chronic Myeloid Leukemia with a PPAR-gamma Agonist.
    N Engl J Med. 2015;373:1973-5.
    PubMed     Text format     Abstract available


    October 2015
  44. HUNGER SP, Mullighan CG
    Acute Lymphoblastic Leukemia in Children.
    N Engl J Med. 2015;373:1541-52.
    PubMed     Text format    


    September 2015
  45. FALINI B, Brunetti L, Martelli MP
    Dactinomycin in NPM1-Mutated Acute Myeloid Leukemia.
    N Engl J Med. 2015;373:1180-2.
    PubMed     Text format    


  46. DOHNER H, Weisdorf DJ, Bloomfield CD
    Acute Myeloid Leukemia.
    N Engl J Med. 2015;373:1136-52.
    PubMed     Text format    


  47. TIACCI E, Park JH, De Carolis L, Chung SS, et al
    Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia.
    N Engl J Med. 2015.
    PubMed     Text format     Abstract available


    July 2015
  48. GELLER BJ, Stone RM, Merola JF, Levy BD, et al
    CLINICAL PROBLEM-SOLVING. A Man with Fever, Cough, and Rash.
    N Engl J Med. 2015;373:74-80.
    PubMed     Text format    


  49. YOSHIZATO T, Dumitriu B, Hosokawa K, Makishima H, et al
    Somatic Mutations and Clonal Hematopoiesis in Aplastic Anemia.
    N Engl J Med. 2015;373:35-47.
    PubMed     Text format     Abstract available


    May 2015
  50. SCHOENTHALER R
    Lessons in medicine, mortality, and reflexive verbs.
    N Engl J Med. 2015;372:1787-9.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: